Areas of Interest

"From experience we know that working with exceptional partners, regardless of size, geography, or setting, will enhance Sanofi's capacity to break new ground on many disease fronts, including those most relevant to our recent collaborations that focus on multiple myeloma and other cancer treatments as well as autoimmune and inflammatory diseases."

John Reed, Head of Global R&D

Immunology
Oncology
Neuroscience
Rare DIseases
Human Vaccines
General Medicines
China and Emerging Markets
Consumer Healthcare
Digital
Technology Platforms
Out-Licensing